Pediatric Telehealth Platform Global Market Report 2025

A pediatric telehealth platform is a digital solution that leverages telecommunications technology to enable healthcare providers to deliver medical treatment, consultations, and monitoring services to children remotely. It supports virtual appointments, reduces the need for travel, and allows timely diagnosis and care, thereby improving access to pediatric healthcare - especially for families in remote or underserved areas.

The primary components of pediatric telehealth platforms include software, hardware, and services. Software consists of the applications and programs that drive the platform’s functionality. These platforms support software by offering efficient digital tools for consultations, managing patient data, and performing diagnoses, enabling remote care delivery. Key functionalities often include appointment scheduling, management of medical histories, prescription tracking, diagnostic tools, and educational resources for patients. The delivery methods include web-based, cloud-based, and on-premises platforms. The applications address various health issues such as respiratory conditions, colds, flu, fever, gastroenterology, behavioral health, dermatology, and others. End-users include hospitals, clinics, homecare providers, schools, and additional care settings.

Paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are rare, life-threatening blood disorders caused by the uncontrolled activation of the complement system, a component of the immune system. PNH results in the destruction of red blood cells, while aHUS leads to the formation of blood clots in small blood vessels, primarily affecting the kidneys and other vital organs.

The main treatments for PNH and aHUS include Soliris and Ultomiris. Soliris, also known by its generic name eculizumab, is a monoclonal antibody medication used to treat these rare blood disorders. The treatment options for these conditions include complement inhibitors, plasma exchange or infusion, and others. Diagnostic methods involve clinical diagnosis, genetic testing, and biomarker testing. These treatments and diagnostic methods are used by various end-users, including hospitals, specialty clinics, research institutes, and more.

The paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market research report is one of a series of new reports that provides paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market statistics, including the paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) industry's global market size, regional shares, competitors with the paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market share, detailed paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market segments, market trends and opportunities, and any further data you may need to thrive in the paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market. This paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market size has grown strongly in recent years. It will grow from $5.57 billion in 2024 to $5.99 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to factors such as the increasing prevalence of PNH and aHUS, rising investment in rare disease research, growing demand for targeted therapies, increased awareness of PNH and aHUS, and the growing adoption of complement inhibitors.

The paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) market size is expected to see strong growth in the next few years. It will grow to $7.93 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be attributed to factors such as increasing regulatory approvals for new treatments, growing collaboration between biotech companies and research institutes, rising demand for personalized medicine, increasing investment in rare disease startups, and a growing number of clinical trials and research studies. Key trends in the forecast period include advancements in complement inhibition therapies, the integration of gene therapy approaches, developments in personalized medicine, technology-driven diagnostic tools, and the integration of technology for remote patient monitoring.

The pediatric telehealth platform market research report is one of a series of new reports that provides pediatric telehealth platform market statistics, including pediatric telehealth platform industry global market size, regional shares, competitors with a pediatric telehealth platform market share, detailed pediatric telehealth platform market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric telehealth platform industry. This pediatric telehealth platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric telehealth platform market size has grown exponentially in recent years. It will grow from $1.37 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth observed in the historical period can be attributed to several factors, including the rising demand for remote healthcare services, increasing pediatric healthcare expenses, growing use of mobile health applications, the expansion of telecommunication infrastructure, and the higher prevalence of chronic conditions in children.

The pediatric telehealth platform market size is expected to see exponential growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 22.5%. The anticipated growth in the forecast period is driven by factors such as the growing adoption of digital health solutions, improved healthcare access in rural regions, an increasing focus on convenience and efficiency, heightened awareness of the benefits of telehealth, and the broader inclusion of telehealth services in insurance coverage. Key trends for the forecast period include advancements in telemedicine platforms, innovations in remote monitoring devices for children, the development of AI-driven healthcare tools, the integration of telehealth with wearable health technology, and ongoing research into pediatric-specific telehealth solutions.

The growing adoption of digital health solutions is expected to drive the expansion of the pediatric telehealth platform market. Digital health solutions encompass various technologies such as mobile apps, telemedicine, wearable devices, and electronic health records, all aimed at enhancing healthcare delivery and patient outcomes. This shift is largely fueled by the increasing demand for remote patient monitoring, as healthcare providers seek efficient methods to track patient data in real time, beyond traditional clinical environments. Pediatric telehealth platforms play a crucial role in this transformation by offering remote consultations and continuous health monitoring, improving access to care, and reducing the need for in-person visits. For example, in April 2023, FAIR Health Inc. reported a 7.3% increase in national telehealth usage, rising from 5.5% in December 2022 to 5.9% in January 2023. Consequently, the growing adoption of digital health solutions is contributing to the growth of the pediatric telehealth platform market.

Companies in the pediatric telehealth platform sector are increasingly focused on developing innovative digital communication tools to enhance accessibility, engage patients, and ensure timely care for children through convenient, user-friendly communication methods. These digital tools facilitate the exchange of information electronically, enabling healthcare providers to remotely interact with patients and caregivers, which ensures timely consultations, follow-ups, and care coordination without the need for in-person visits. For example, in November 2024, Summer Health Inc. launched a free trial of its messaging-based pediatric care platform, offering 24/7 text access to licensed pediatricians across all 50 states. This service provides expert assessments, referrals, and prescriptions within 15 minutes, helping parents manage conditions such as RSV, flu, and COVID-19 at home, thereby reducing unnecessary emergency room visits.

In July 2024, Fabric Health Inc., a US-based healthcare technology company, acquired MeMD Inc. from Walmart to expand its virtual care offerings. This acquisition is aimed at enhancing Fabric Health’s virtual care services and strengthening its market position. By leveraging MeMD's established customer base, technology, and team, Fabric Health plans to provide comprehensive care solutions to a larger audience. MeMD Inc. is a telehealth platform offering urgent care for both adults and children, providing 24/7 treatment for routine health issues.

Major players in the pediatric telehealth platform market are Teladoc Health Inc., American Well Corporation, Health Catalyst Inc., Brightline Holdings LLC, HealthTap, Sesame Inc., Health Recovery Solutions Inc., Hazel Health Inc., BabyScripts, Kiddo Health Inc., Kismet Health Inc., CareFirst Pediatrics, Blueberry Pediatrics, Maven Technosoft Private Limited, Alpha Medical Group Inc., Virtuwell, Summer Health Inc., Omega Pediatrics, Tele-Medics Solutions Private Limited, and Anytime Telecare.

North America was the largest region in the pediatric telehealth platform market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric telehealth platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pediatric telehealth platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric telehealth platform market consists of revenues earned by entities providing services such as virtual consultations, remote patient monitoring, electronic prescriptions, and pediatric health assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric telehealth platform market also includes sales of digital diagnostic tools, remote monitoring devices, tablets, webcams, and other connected medical equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.